Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mehnert, Janice"'
Autor:
Silk AW; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., O'Day SJ; John Wayne Cancer Institute, Santa Monica, CA, USA., Kaufman HL; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA., Bryan J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Virginia Mason Cancer Institute, Seattle, WA, USA., Norrell JT; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Imbergamo C; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Portal D; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Zambrano-Acosta E; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Palmeri M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.; Rutgers New Jersey Medical School, Newark, NJ, USA., Fein S; CNF Pharma, LLC, New City, NY, USA., Wu C; Merck & Co., Inc, Rahway, NJ, USA., Guerreiro L; Merck & Co., Inc, Rahway, NJ, USA., Medina D; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Bommareddy PK; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers Graduate School of Biomedical Sciences, New Brunswick, NJ, USA., Zloza A; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.; Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Cancer Center, Rush University Medical Center, Chicago, IL, USA., Fox BA; Earle A. Chiles Research Institute in the Providence Cancer Institute, Portland, OR, USA., Ballesteros-Merino C; Earle A. Chiles Research Institute in the Providence Cancer Institute, Portland, OR, USA., Ren Y; Merck & Co., Inc, Rahway, NJ, USA., Shafren D; ImmvirX Pty Ltd, New Lambton Heights, NSW, Australia., Grose M; Viralytics Limited, a Wholly Owned Subsidiary of Merck & Co., Inc., Rahway, NJ, USA., Vieth JA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.; JDRF International, New York, NY, USA., Mehnert JM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. janice.mehnert@nyulangone.org.; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. janice.mehnert@nyulangone.org.; Melanoma and Cutaneous Oncology, Laura and Isaac Perlmutter Cancer Center at NYU, New York University Langone Medical Center, 522 First Ave, SML1304, New York, NY, 10016, USA. janice.mehnert@nyulangone.org.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Jun; Vol. 72 (6), pp. 1405-1415. Date of Electronic Publication: 2022 Nov 29.
Autor:
Tan AR; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Antoinette.Tan@atriumhealth.org.; Atrium Health, Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA. Antoinette.Tan@atriumhealth.org., Chan N; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Kiesel BF; University of Pittsburgh, Pittsburgh, PA, USA., Stein MN; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Columbia University Medical Center, New York, NY, USA., Moss RA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Malhotra J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Aisner J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Shah M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Gounder M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Lin H; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Kane MP; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Ji J; Frederick National Lab for Cancer Research, Bethesda, MD, USA., Chen A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Beumer JH; University of Pittsburgh, Pittsburgh, PA, USA., Mehnert JM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; New York University Langone Health's Perlmutter Cancer Center, New York, NY, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Jan; Vol. 89 (1), pp. 49-58. Date of Electronic Publication: 2021 Oct 20.
Autor:
Mehnert JM; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA. mehnerja@rutgers.cinj.edu., Kaveney AD; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Malhotra J; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Spencer K; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Portal D; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Goodin S; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Tan AR; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Aisner J; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Moss RA; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Lin H; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Bertino JR; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Gibbon D; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Doyle LA; National Cancer Institute-Cancer Therapy Evaluation Program, Bethesda, MD, USA., White EP; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA., Stein MN; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2019 Oct; Vol. 84 (4), pp. 899-907. Date of Electronic Publication: 2019 Aug 28.
Autor:
D'Angelo SP; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, 300 East 66th Street, 12th Floor, New York, NY, 10065, USA. dangelos@mskcc.org., Hunger M; Mapi (An ICON plc Company), Munich, Germany., Brohl AS; Moffitt Cancer Center, Tampa, FL, USA., Nghiem P; Division of Dermatology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA., Bhatia S; Division of Medical Oncology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA., Hamid O; The Angeles Clinic and Research Institute, Los Angeles, CA, USA., Mehnert JM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Terheyden P; University of Lübeck, Lübeck, Germany., Shih KC; Tennessee Oncology, Nashville, TN, USA., Brownell I; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Lebbé C; Hôpital Saint-Louis, Paris, France., Lewis KD; University of Colorado Cancer Center, Anschutz, Aurora, CO, USA., Linette GP; Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Milella M; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Schlichting M; Merck KGaA, Darmstadt, Germany., Hennessy MH; EMD Serono, Billerica, MA, USA., Bharmal M; Merck KGaA, Darmstadt, Germany.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Apr; Vol. 68 (4), pp. 609-618. Date of Electronic Publication: 2019 Feb 05.